UBS Group’s Cyclacel Pharmaceuticals CYCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98K | Sell |
5,985
-56,264
| -90% | -$18.6K | ﹤0.01% | 8214 |
|
|
2025
Q1 | $17.4K | Buy |
62,249
+14,932
| +32% | +$4.17K | ﹤0.01% | 7017 |
|
|
2024
Q4 | $17.8K | Buy |
47,317
+34,764
| +277% | +$13.1K | ﹤0.01% | 6723 |
|
|
2024
Q3 | $12.4K | Sell |
12,553
-25,426
| -67% | -$25.2K | ﹤0.01% | 6425 |
|
|
2024
Q2 | $61.5K | Buy |
37,979
+33,144
| +686% | +$53.7K | ﹤0.01% | 5386 |
|
|
2024
Q1 | $10.2K | Buy |
+4,835
| New | +$10.2K | ﹤0.01% | 6068 |
|
|
2023
Q3 | – | Sell |
-171
| Closed | -$101 | – | 8349 |
|
|
2023
Q2 | $101 | Buy |
+171
| New | +$101 | ﹤0.01% | 7423 |
|
|
2022
Q4 | – | Sell |
-2,322
| Closed | -$3K | – | 9544 |
|
|
2022
Q3 | $3K | Buy |
2,322
+220
| +10% | +$284 | ﹤0.01% | 8414 |
|
|
2022
Q2 | $2K | Sell |
2,102
-2,422
| -54% | -$2.3K | ﹤0.01% | 8482 |
|
|
2022
Q1 | $14K | Buy |
4,524
+3,100
| +218% | +$9.59K | ﹤0.01% | 6879 |
|
|
2021
Q4 | $6K | Buy |
+1,424
| New | +$6K | ﹤0.01% | 8137 |
|
|
2021
Q3 | – | Sell |
-72
| Closed | – | – | 8413 |
|
|
2021
Q2 | $0 | Sell |
72
-2,280
| -97% | – | ﹤0.01% | 8301 |
|
|
2021
Q1 | $17K | Buy |
2,352
+2,350
| +117,500% | +$17K | ﹤0.01% | 6483 |
|
|
2020
Q4 | $0 | Sell |
2
-2,992
| -100% | – | ﹤0.01% | 7386 |
|
|
2020
Q3 | $11K | Buy |
2,994
+2,992
| +149,600% | +$11K | ﹤0.01% | 5878 |
|
|
2020
Q2 | $0 | Sell |
2
-11,430
| -100% | – | ﹤0.01% | 7089 |
|
|
2020
Q1 | $4K | Buy |
11,432
+3,805
| +50% | +$1.33K | ﹤0.01% | 6456 |
|
|
2019
Q4 | $5K | Sell |
7,627
-16,971
| -69% | -$11.1K | ﹤0.01% | 6490 |
|
|
2019
Q3 | $10K | Buy |
24,598
+24,374
| +10,881% | +$9.91K | ﹤0.01% | 6189 |
|
|
2019
Q2 | $0 | Sell |
224
-850
| -79% | – | ﹤0.01% | 6987 |
|
|
2019
Q1 | $1K | Sell |
1,074
-7,019
| -87% | -$6.54K | ﹤0.01% | 6688 |
|
|
2018
Q4 | $5K | Buy |
8,093
+7,910
| +4,322% | +$4.89K | ﹤0.01% | 6608 |
|
|
2018
Q3 | $0 | Sell |
183
-10,197
| -98% | – | ﹤0.01% | 7043 |
|
|
2018
Q2 | $14K | Buy |
10,380
+7,424
| +251% | +$10K | ﹤0.01% | 6013 |
|
|
2018
Q1 | $4K | Buy |
2,956
+801
| +37% | +$1.08K | ﹤0.01% | 6422 |
|
|
2017
Q4 | $3K | Sell |
2,155
-1,200
| -36% | -$1.67K | ﹤0.01% | 6545 |
|
|
2017
Q3 | $6K | Buy |
3,355
+3,175
| +1,764% | +$5.68K | ﹤0.01% | 6217 |
|
|
2017
Q2 | $1K | Sell |
180
-2,006
| -92% | -$11.1K | ﹤0.01% | 6530 |
|
|
2017
Q1 | $8K | Buy |
2,186
+88
| +4% | +$322 | ﹤0.01% | 5817 |
|
|
2016
Q4 | $11K | Buy |
+2,098
| New | +$11K | ﹤0.01% | 5899 |
|
|
2016
Q2 | – | Sell |
-2,227
| Closed | -$1K | – | 6797 |
|
|
2016
Q1 | $1K | Sell |
2,227
-4,816
| -68% | -$2.16K | ﹤0.01% | 6532 |
|
|
2015
Q4 | $4K | Buy |
7,043
+25
| +0.4% | +$14 | ﹤0.01% | 6382 |
|
|
2015
Q3 | $4K | Sell |
7,018
-7,282
| -51% | -$4.15K | ﹤0.01% | 6359 |
|
|
2015
Q2 | $12K | Buy |
14,300
+8,446
| +144% | +$7.09K | ﹤0.01% | 5855 |
|
|
2015
Q1 | $5K | Sell |
5,854
-1,323
| -18% | -$1.13K | ﹤0.01% | 6171 |
|
|
2014
Q4 | $5K | Buy |
+7,177
| New | +$5K | ﹤0.01% | 6335 |
|